EFPIA hires director of European affairs
March 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, kuiper
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed Elizabeth Kuiper to be the director of its European …
Parexel expands international operation
March 25, 2014Manufacturing and Production, Sales and Marketing Parexel, Singapore, manufacturing
Biopharma services provider Parexel International Corporation is beefing up its global capacity and adding more secondary packaging and labelling services …
Xolair gets FDA approval for skin condition
March 24, 2014Research and Development, Sales and Marketing FDA, Novartis, Roche, Sanofi, Xolair, chronic hives, csu
An asthma drug developed by Roche subsidiary Genentech and Novartis has been granted an additional indication to treat chronic hives …
CHMP recommends Jardiance
March 24, 2014Research and Development, Sales and Marketing Boehringer, CHMP, EU, diabetes, jardiance, lilly
Boehringer Ingelheim and Eli Lilly’s type 2 diabetes treatment Jardiance is among nine medicines which the Committee for Medicinal Products …
Endocyte lung cancer drug shows promise
March 24, 2014Research and Development, Sales and Marketing Endocyte, MSD, NSCLC, lung cancer, vintafolide
Endocyte and partner MSD have released positive mid-stage trial results for their investigational lung cancer drug vintafolide. The treatment met …
NICE says ‘no’ to Xofigo
March 24, 2014Sales and Marketing Bayer, CDF, NHS, NICE, abiraterone, prostate, xofigo
NICE has dealt Bayer a severe blow by not approving prostate cancer drug Xofigo for use on the NHS in …
Former Google head to lead comms for M3

March 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cowderoy, doctors.net, google, m3
Healthcare information provider M3 has appointed the former head of healthcare at Google as its managing director of communications in …
Data transparency debate: Europe decides its future
March 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency
Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …
NICE approves Velcade
March 21, 2014Sales and Marketing Janssen, NHS, NICE, Velcade, myeloma
NICE has recommended Janssen’s proteasome inhibitor Velcade as an induction treatment for some patients with newly-diagnosed multiple myeloma. The draft …
IBM supercomputer could hold key to brain cancer
March 21, 2014Medical Communications, Sales and Marketing avastin, brain cancer, ibm, nygc, supercomputer
The New York Genome Center and IBM Watson have joined forces to accelerate a new era of genomic medicine, initially …
Amgen names senior VP of Business Development
March 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, David Piacquad
Amgen has confirmed the appointment of David Piacquad to the new position of senior vice president of its Business Development …
EMA launches speedy pilot
March 21, 2014Sales and Marketing BIA, EMA, MHRA, NICE, early access, trials
The European Medicines Agency (EMA) has launched an initiative aimed at speeding up the drug approval process and wants help …
AstraZeneca banks on MasterCard for director
March 20, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Johansson, ann cairns, british gas, mastercard
AstraZeneca is proposing to elect the president of International Markets for MasterCard to stand as a non-executive director on its …
AstraZeneca signs Vodafone contract
March 20, 2014Medical Communications, Sales and Marketing AstraZeneca, cardiovascular, mhealth, vodaphone
AstraZeneca has signed up with phone operator Vodafone to provide mobile health (mHealth) services for patients suffering from cardiovascular issues. …
GSK cancer vaccine fails again
March 20, 2014Sales and Marketing Cancer, GSK, MAGE-A3 cancer immunotherapeutic, NSCLC, lung cancer, melanoma
GlaxoSmithKline’s MAGE-A3 cancer immunotherapeutic has delivered another late-stage blow to the firm but it still vows to continue trials. The …
BIA welcomes budget statement
March 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Budget, Osborne, R&D, seed, sme
An increase in R&D tax credits and the creation of a cell therapy manufacturing centre were two of the highlights …
Takeda hires head of emerging markets
March 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, giles platford
Giles Platford has been appointed head of commercial operations, emerging markets for Swiss-based pharma firm Takeda. Reporting to its chief …
FDA ‘not trusted’ by Americans
March 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, JAMA, MMR, US, america, conspiracy, yougov
More than one-third of Americans in a new survey think the Food and Drug Administration is holding back new cures …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
